Varian Medical Systems, Inc. (NYSE:VAR) SVP John W. Kuo sold 3,876 shares of the business’s stock in a transaction on Friday, March 17th. The stock was sold at an average price of $91.75, for a total transaction of $355,623.00. Following the completion of the transaction, the senior vice president now owns 30,926 shares in the company, valued at approximately $2,837,460.50. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Varian Medical Systems, Inc. (NYSE:VAR) traded down 0.01% during midday trading on Monday, hitting $91.51. 860,589 shares of the stock traded hands. The company has a 50-day moving average of $83.72 and a 200-day moving average of $90.56. The stock has a market cap of $8.55 billion, a PE ratio of 26.06 and a beta of 0.69. Varian Medical Systems, Inc. has a 1-year low of $67.26 and a 1-year high of $93.56.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Your IP Address:

This article was originally published by and is the sole property of American Banking News. If you happen to be reading this article on another website, it was stolen and illegally republished in violation of U.S. and International copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2017/03/20/john-w-kuo-sells-3876-shares-of-varian-medical-systems-inc-var-stock.html

Hedge funds and other institutional investors have recently made changes to their positions in the company. Penserra Capital Management LLC raised its position in shares of Varian Medical Systems by 100.0% in the third quarter. Penserra Capital Management LLC now owns 1,260 shares of the company’s stock valued at $125,000 after buying an additional 630 shares during the period. Ladenburg Thalmann Financial Services Inc. raised its position in shares of Varian Medical Systems by 22.5% in the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 1,946 shares of the company’s stock valued at $180,000 after buying an additional 357 shares during the period. Advisor Group Inc. raised its position in shares of Varian Medical Systems by 10.3% in the third quarter. Advisor Group Inc. now owns 1,997 shares of the company’s stock valued at $194,000 after buying an additional 186 shares during the period. FineMark National Bank & Trust raised its position in shares of Varian Medical Systems by 873.8% in the third quarter. FineMark National Bank & Trust now owns 2,006 shares of the company’s stock valued at $200,000 after buying an additional 1,800 shares during the period. Finally, Buckingham Asset Management LLC acquired a new position in shares of Varian Medical Systems during the third quarter valued at approximately $203,000. Institutional investors own 99.79% of the company’s stock.

A number of brokerages have commented on VAR. Jefferies Group LLC reiterated a “buy” rating and issued a $102.00 price objective on shares of Varian Medical Systems in a report on Thursday, December 1st. Aegis began coverage on shares of Varian Medical Systems in a report on Monday, February 6th. They issued a “hold” rating and a $85.00 price objective on the stock. Royal Bank of Canada reiterated a “sector perform” rating and issued a $93.00 price objective (up previously from $91.00) on shares of Varian Medical Systems in a report on Monday, January 23rd. Barrington Research boosted their price objective on shares of Varian Medical Systems from $98.00 to $102.00 and gave the stock an “outperform” rating in a report on Friday, January 27th. Finally, TheStreet lowered shares of Varian Medical Systems from a “b-” rating to a “c” rating in a report on Wednesday, February 8th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $92.15.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

5 Day Chart for NYSE:VAR

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.